Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?

BACKGROUND: Insulin resistance (IR) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (NAFLD). Therefore, correction of IR is a relevant therapeutic target. We performed the current trial to evaluate whether 12- month m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shargorodsky, Marina, Omelchenko, Elena, Matas, Zipora, Boaz, Mona, Gavish, Dov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471007/
https://www.ncbi.nlm.nih.gov/pubmed/22676459
http://dx.doi.org/10.1186/1475-2840-11-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471007/
https://www.ncbi.nlm.nih.gov/pubmed/22676459
http://dx.doi.org/10.1186/1475-2840-11-61

Ejemplares similares